secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001437749-23-016148
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Director Mitchell Levinson leaves Pulse Biosciences board; continues as CSO
---------------------------------------------------------------------------

- Mitchell E. Levinson did not stand for reelection at the 2023 annual meeting, no disagreement cited.
- All six director nominees elected; votes ranged from 22.3M to 23.3M for, with under 1M against per nominee.
- Ratification of Deloitte & Touche as auditor passed with ~31.95M for, ~31K against.
- Annual meeting held virtually on May 25, 2023; results filed in 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774923016148/0001437749-23-016148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774923016148/plse20230526_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-016148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer